TMS Device NeuroStar Cleared as Add-On Treatment for Adolescent Depression
The clearance was based on real-world data from the TrakStar platform, which included 1169 adolescents.
Source: empr.com
Page 2 - Keithj Sullivan News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Keithj Sullivan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Keithj Sullivan Today - Breaking & Trending Today
Neuronetics' (STIM) "Market Perform" Rating Reiterated at William Blair
Neuronetics (NASDAQ:STIM – Get Free Report)‘s stock had its “market perform” rating restated by William Blair in a note issued to investors on Tuesday, RTT News reports. Separately, Piper Sandler reiterated an “overweight” rating and issued a $8.00 target price (up previously from $7.00) on shares of Neuronetics in a research report on Wednesday, March […]
Source: wkrb13.com
Neuronetics' (STIM) "Market Perform" Rating Reiterated at William Blair
Neuronetics (NASDAQ:STIM – Get Free Report)‘s stock had its “market perform” rating restated by analysts at William Blair in a research note issued on Tuesday, RTT News reports. Separately, Piper Sandler reaffirmed an “overweight” rating and issued a $8.00 price target (up from $7.00) on shares of Neuronetics in a report on Wednesday, March 6th. […]
Source: tickerreport.com
NeuroStar® Advanced Therapy Receives FDA Clearance as a First-Line Add-On Treatment for Adolescents with Depression
NeuroStar is the first and only TMS therapy cleared as an adjunct treatment for patients ages 15 and olderMALVERN, Pa., March 25, 2024 -- Neuronetics, Inc. , a medical technology company focused on...
Source: marketscreener.com
FDA clears Neuronetics' neurostim for adolescents with depression
Neuronetics announced today that it received FDA clearance for the use of its NeuroStar therapy for adolescent patients.
Source: massdevice.com